Photosensitive lichenoid eruption and inhaled tiotropium bromide [1]

Dermatology

Volumn 214, Issue 1, 2006, Pages 97-98

  Perez Perez L ^a,b   Cabanillas, M ^a   Pereiro Ferreiros M M ^a   Peteiro, C ^a   Toribio, J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Lichenoid eruption; Photosensitive eruption; Tiotropium bromide

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT; SUNSCREEN; TIOTROPIUM BROMIDE;

AGED; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; LABORATORY TEST; LETTER; LICHENOID ERUPTION; MALE; PATCH TEST; PHOTOSENSITIVE LICHENOID ERUPTION; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; AGED; CHOLINERGIC ANTAGONISTS; DERMATITIS, PHOTOALLERGIC; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS; LICHENOID ERUPTIONS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES;

EID: 33845942972     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096922     Document Type: Letter

References (6)

1. Durham MC: Tiotropium (Spiriva): A once-daily inhaled anticholinergic, medication for chronic obstructive pulmonary disease. BUMC Proc 2004;17:366-373.
2. Litt JZ: Drug Eruption Reference Manual, ed 12. Oxon, Taylor & Francis, 2006, p 555.
3. Pham HC, Saurat JH: Inhalation route inducing subacute cutaneous lupus erythematosus with tiotropium. Arch Dermatol 2005;141:911-912.
4. Van de Haute V, Antoine JL, Lachapelle JM: Histopathological discriminant criteria between lichenoid drug eruption and idiopatic lichen planus: retrospective study on selected samples. Dermatologica 1989;179:10-13.
5. Halevy S, Shai A: Lichenoid drug eruptions. J Am Acad Dermatol 1993;29:249-255.
6. Naranjo CA, Busto C, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.